Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus

Objective. A sensitive and specific multiplex fluorescence rapid detection method was established for simultaneous detection of SARS-CoV-2, influenza A virus, and influenza B virus in a self-made device within 30 min, with a minimum detection limit of 200 copies/mL. Methods. Based on the genome sequ...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Ma, Haoyan Zhu, Yongwei Jiang, Xiaomu Kong, Peng Gao, Yi Liu, Meimei Zhao, Guoxiong Deng, Yongtong Cao
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:International Journal of Analytical Chemistry
Online Access:http://dx.doi.org/10.1155/2024/4950391
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408363837784064
author Liang Ma
Haoyan Zhu
Yongwei Jiang
Xiaomu Kong
Peng Gao
Yi Liu
Meimei Zhao
Guoxiong Deng
Yongtong Cao
author_facet Liang Ma
Haoyan Zhu
Yongwei Jiang
Xiaomu Kong
Peng Gao
Yi Liu
Meimei Zhao
Guoxiong Deng
Yongtong Cao
author_sort Liang Ma
collection DOAJ
description Objective. A sensitive and specific multiplex fluorescence rapid detection method was established for simultaneous detection of SARS-CoV-2, influenza A virus, and influenza B virus in a self-made device within 30 min, with a minimum detection limit of 200 copies/mL. Methods. Based on the genome sequences of SARS-CoV-2, influenza A virus (FluA), and influenza B virus (FluB) with reference to the Chinese Center for Disease Control and Prevention and related literature, specific primers were designed, and a multiplex fluorescent PCR system was established. The simultaneous and rapid detection of SARS-CoV-2, FluA, and FluB was achieved by optimizing the concentrations of Taq DNA polymerase as well as primers, probes, and Mg2+. The minimum detection limits of the nucleic acid rapid detection system for SARS-CoV-2, FluA, and FluB were evaluated. Results. By optimizing the amplification system, the N enzyme with the best amplification performance was selected, and the optimal concentration of Mg2+ in the multiamplification system was 3 mmol/L; the final concentrations of SARS-CoV-2 NP probe and primer were 0.15 μmol/L and 0.2 μmol/L, respectively; the final concentrations of SARS-CoV-2 ORF probe and primer were both 0.15 μmol/L; the final concentrations of FluA probe and primer were 0.2 μmol/L and 0.3 μmol/L, respectively; the final concentrations of FluB probe and primer were 0.15 μmol/L and 0.25 μmol/L, respectively. Conclusion. A multiplex real-time quantitative fluorescence RT-PCR system for three respiratory viruses of SARS-CoV-2, FluA, and FluB was established with a high amplification efficiency and sensitivity reaching 200 copies/mL for all samples. Combined with the automated microfluidic nucleic acid detection system, the system can achieve rapid detection in 30 minutes.
format Article
id doaj-art-7989cc53501e4c6a8e62603eac584d49
institution Kabale University
issn 1687-8779
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series International Journal of Analytical Chemistry
spelling doaj-art-7989cc53501e4c6a8e62603eac584d492025-08-20T03:35:48ZengWileyInternational Journal of Analytical Chemistry1687-87792024-01-01202410.1155/2024/4950391Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B VirusLiang Ma0Haoyan Zhu1Yongwei Jiang2Xiaomu Kong3Peng Gao4Yi Liu5Meimei Zhao6Guoxiong Deng7Yongtong Cao8Department of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryDepartment of Clinical LaboratoryObjective. A sensitive and specific multiplex fluorescence rapid detection method was established for simultaneous detection of SARS-CoV-2, influenza A virus, and influenza B virus in a self-made device within 30 min, with a minimum detection limit of 200 copies/mL. Methods. Based on the genome sequences of SARS-CoV-2, influenza A virus (FluA), and influenza B virus (FluB) with reference to the Chinese Center for Disease Control and Prevention and related literature, specific primers were designed, and a multiplex fluorescent PCR system was established. The simultaneous and rapid detection of SARS-CoV-2, FluA, and FluB was achieved by optimizing the concentrations of Taq DNA polymerase as well as primers, probes, and Mg2+. The minimum detection limits of the nucleic acid rapid detection system for SARS-CoV-2, FluA, and FluB were evaluated. Results. By optimizing the amplification system, the N enzyme with the best amplification performance was selected, and the optimal concentration of Mg2+ in the multiamplification system was 3 mmol/L; the final concentrations of SARS-CoV-2 NP probe and primer were 0.15 μmol/L and 0.2 μmol/L, respectively; the final concentrations of SARS-CoV-2 ORF probe and primer were both 0.15 μmol/L; the final concentrations of FluA probe and primer were 0.2 μmol/L and 0.3 μmol/L, respectively; the final concentrations of FluB probe and primer were 0.15 μmol/L and 0.25 μmol/L, respectively. Conclusion. A multiplex real-time quantitative fluorescence RT-PCR system for three respiratory viruses of SARS-CoV-2, FluA, and FluB was established with a high amplification efficiency and sensitivity reaching 200 copies/mL for all samples. Combined with the automated microfluidic nucleic acid detection system, the system can achieve rapid detection in 30 minutes.http://dx.doi.org/10.1155/2024/4950391
spellingShingle Liang Ma
Haoyan Zhu
Yongwei Jiang
Xiaomu Kong
Peng Gao
Yi Liu
Meimei Zhao
Guoxiong Deng
Yongtong Cao
Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
International Journal of Analytical Chemistry
title Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
title_full Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
title_fullStr Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
title_full_unstemmed Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
title_short Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
title_sort development of a novel multiplex pcr method for the rapid detection of sars cov 2 influenza a virus and influenza b virus
url http://dx.doi.org/10.1155/2024/4950391
work_keys_str_mv AT liangma developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT haoyanzhu developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT yongweijiang developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT xiaomukong developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT penggao developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT yiliu developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT meimeizhao developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT guoxiongdeng developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus
AT yongtongcao developmentofanovelmultiplexpcrmethodfortherapiddetectionofsarscov2influenzaavirusandinfluenzabvirus